Pharmaceutical

Chime Biologics, Leads and Beigene enter antibody development deal

Chime Biologics, Leads Biolabs and BeiGene have entered a strategic partnership to expedite the development of a monoclonal antibody, LBL-007.

Jul 3, 2023 - 20:00
Chime Biologics, Leads and Beigene enter antibody development deal
Chime Biologics, Leads Biolabs and BeiGene have entered a strategic partnership to expedite the development of a monoclonal antibody, LBL-007.
Read the original article

Tags:

Previous Article

Madrigal seeks expedited approval for NASH treatment

Next Article

Knowledge powerhouses urged to join pioneering Africa-led mission to level up gl...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Harmony wins orphan drug tag for pitolisant to treat Prader-Willi syndrome 

Harmony wins orphan drug tag for pitolisant to treat Pr...

Feb 22, 2024

Opinion: A new Louisiana capital-punishment bill would fundamentally alter physician licensing

Opinion: A new Louisiana capital-punishment bill would ...

Feb 27, 2024

ASCO 2024: Novartis’ Scemblix outperforms standard of care in CML

ASCO 2024: Novartis’ Scemblix outperforms standard of c...

Jun 2, 2024